---
figid: PMC6112840__oncotarget-09-31958-g008
figtitle: Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical
  vein endothelial cells via blocking VEGFR signaling pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Armoracia rusticana
- Diaporthe sclerotioides
- Oryzias latipes
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC6112840
filename: oncotarget-09-31958-g008.jpg
figlink: /pmc/articles/PMC6112840/figure/F8/
number: F8
caption: . Schematic illustration of potential action mechanisms of Ponatinib in angiogenesis.
papertitle: Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical
  vein endothelial cells via blocking VEGFR signaling pathway.
reftext: Nana Ai, et al. Oncotarget. 2018 Aug 10;9(62):31958-31970.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9394546
figid_alias: PMC6112840__F8
figtype: Figure
redirect_from: /figures/PMC6112840__F8
ndex: 082b203c-def1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6112840__oncotarget-09-31958-g008.html
  '@type': Dataset
  description: . Schematic illustration of potential action mechanisms of Ponatinib
    in angiogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - EPHB2
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - NOS3
  - ENO4
  - Vegfa
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Ephb2
  - Mapk1
  - Akt1
  - Nos3
  - Ephb1
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Erk7
  - rl
  - Akt
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Ponatinib
---
